Summary
Sprint Bioscience AB (Sprint Bioscience) is a pharmaceutical company that discovers and develops pharmaceuticals in the areas of cancer and metabolism. The company’s products include cancer metabolism, autophagy and amino acid metabolism. Its projects include PIP4K2a, and Vps34, established FBDD project, develop in vivo candidate and develop clinical candidate. Sprint Bioscience builds drug discovery pipeline of innovative targets within oncology. It also offers out-licensing whch include from the discovery phase to clinical trials. The company focuses on cancer metabolism and lipid signaling. It expertise’s in metabolism that applies outside the cancer area and also evaluates projects in the areas of diabetes. The company collaborates with universities and individual researchers. Sprint Bioscience is headquartered in Huddinge, Sweden.
Sprint Bioscience AB (SPRINT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Sprint Bioscience AB, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Sprint Bioscience AB, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Sprint Bioscience AB, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Sprint Bioscience AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Sprint Bioscience AB, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Sprint Bioscience AB, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Sprint Bioscience Raises Funds Through Venture Financing 10
Partnerships 11
TPP Global Development Enters Into Agreement With Sprint Biosciences To Develop Choline Kinase Inhibitors 11
Licensing Agreements 12
Sprint Bioscience Enters into Licensing Agreement with Bayer HealthCare 12
Equity Offering 13
Sprint Bioscience to Raise USD2.3 Million in Private Placement of Shares 13
Sprint Bioscience Raises USD3 Million in IPO 14
Asset Transactions 15
Kancera Acquires PFKFB3 from Sprint Bioscience 15
Sprint Bioscience AB - Key Competitors 16
Key Employees 17
Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19
List of Tables
Sprint Bioscience AB, Pharmaceuticals & Healthcare, Key Facts, 2014 1
Sprint Bioscience AB, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Sprint Bioscience AB, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Sprint Bioscience AB, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Sprint Bioscience AB, Deals By Therapy Area, 2010 to YTD 2016 8
Sprint Bioscience AB, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Sprint Bioscience Raises Funds Through Venture Financing 10
TPP Global Development Enters Into Agreement With Sprint Biosciences To Develop Choline Kinase Inhibitors 11
Sprint Bioscience Enters into Licensing Agreement with Bayer HealthCare 12
Sprint Bioscience to Raise USD2.3 Million in Private Placement of Shares 13
Sprint Bioscience Raises USD3 Million in IPO 14
Kancera Acquires PFKFB3 from Sprint Bioscience 15
Sprint Bioscience AB, Key Competitors 16
Sprint Bioscience AB, Key Employees 17
List of Figures
Sprint Bioscience AB, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Sprint Bioscience AB, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Sprint Bioscience AB, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Sprint Bioscience AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Sprint Bioscience AB, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Sprint Bioscience AB, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Sprint Bioscience AB, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Sprint Bioscience AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8